Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 451,501 | 256,380 | 254,568 | 348,930 | 149,287 |
| Marketable Securities | 388 | 40,602 | 36,592 | N/A | N/A |
| Receivables | 20,144 | 12,277 | 12,350 | 16,808 | 18,671 |
| Inventories | 275 | 250 | 118 | 175 | 179 |
| Other current assets | 15,333 | 13,712 | 8,870 | 5,202 | 7,266 |
| TOTAL | $487,641 | $323,221 | $312,498 | $371,116 | $175,403 |
| Non-Current Assets | |||||
| PPE Net | 10,041 | 7,226 | 16,900 | 5,600 | 3,468 |
| Intangibles | 1,268 | 1,431 | 1,343 | 1,062 | 1,363 |
| Other Non-Current Assets | 1,891 | 1,004 | 691 | 938 | 2,627 |
| TOTAL | $13,200 | $9,661 | $18,934 | $7,600 | $7,459 |
| Total Assets | $500,840 | $332,882 | $331,432 | $378,715 | $182,862 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 21 | 1,730 | 2,133 | 1,145 |
| Accounts payable and accrued liabilities | 15,883 | 9,460 | 9,722 | 7,341 | 13,025 |
| Other current liabilities | 9,899 | 7,997 | 5,790 | 15,157 | 6,257 |
| TOTAL | $46,869 | $45,453 | $56,171 | $85,434 | $99,481 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,018 | 13 | 30 | 73 | 3,753 |
| Deferred Revenues | 20,754 | 27,975 | 38,929 | 60,803 | 79,053 |
| aiOther Non-Current Liabilities | 12,321 | 7,745 | 560 | 295 | 1,847 |
| TOTAL | $3,699 | $3,443 | $590 | $559 | $4,281 |
| Total Liabilities | $50,568 | $48,897 | $56,761 | $85,993 | $103,762 |
| Shareholders' Equity | |||||
| Common Shares | 2,765 | 2,367 | 2,332 | 1,953 | 1,956 |
| Retained earnings | -405,321 | -353,070 | -275,130 | -175,146 | -176,087 |
| Other shareholders' equity | 24,303 | 20,651 | -20,716 | -1,210 | -3,018 |
| TOTAL | $450,272 | $283,985 | $274,671 | $292,723 | $79,100 |
| Total Liabilities And Equity | $500,840 | $332,882 | $331,432 | $378,715 | $182,862 |